Alternative splicing and tumor progression.
Alternative splicing and tumor progression.
复制标题
DOI:
10.2174/138920208786847971
复制
发表时间:
2008-12
期刊:
影响因子:
2.6
通讯作者:
Biamonti G
中科院分区:
文献类型:
--
作者:
Ghigna C;Valacca C;Biamonti G
Alternative splicing is a key molecular mechanism for increasing the functional diversity of the eukaryotic proteomes. A large body of experimental data implicates aberrant splicing in various human diseases, including cancer. Both mutations in cis-acting splicing elements and alterations in the expression and/or activity of splicing regulatory factors drastically affect the splicing profile of many cancer-associated genes. In addition, the splicing profile of several cancer-associated genes is altered in particular types of cancer arguing for a direct role of specific splicing isoforms in tumor progression. Deciphering the mechanisms underlying aberrant splicing in cancer may prove crucial to understand how splicing machinery is controlled and integrated with other cellular processes, in particular transcription and signaling pathways. Moreover, the characterization of splicing deregulation in cancer will lead to a better comprehension of malignant transformation. Cancer-associated alternative splicing variants may be new tools for the diagnosis and classification of cancers and could be the targets for innovative therapeutical interventions based on highly selective splicing correction approaches.
登录
查看更多内容
影响因子:
14.9
作者:
Cartegni, L;Wang, JH;Krainer, AR
通讯作者:
Krainer, AR
影响因子:
56.9
作者:
CACERES, JF;STAMM, S;KRAINER, AR
通讯作者:
KRAINER, AR
影响因子:
11.2
作者:
Filippov, Valery;Filippova, Maria;Duerksen-Hughes, Penelope J.
通讯作者:
Duerksen-Hughes, Penelope J.
影响因子:
4.8
作者:
Galiana-Arnoux, D;Lejeune, F;Del Gatto-Konczak, F
通讯作者:
Del Gatto-Konczak, F
影响因子:
11.5
作者:
Devi, GR;Beer, TM;Iversen, PL
通讯作者:
Iversen, PL